A validated LC–MS/MS method for the simultaneous determination of BMS-791325, a hepatitis C virus NS5B RNA polymerase inhibitor, and its metabolite in plasma-Reference-Cited by-同舟云学术

A validated LC–MS/MS method for the simultaneous determination of BMS-791325, a hepatitis C virus NS5B RNA polymerase inhibitor, and its metabolite in plasma

Published:2014-12 Issue: Volume:973 Page:1-8
ISSN:1570-0232
Container-title:Journal of Chromatography B
language:en
Short-container-title:Journal of Chromatography B

Author:

Yuan Long,Jiang Hao,Zheng Naiyu,Xia Yuan-Qing,Ouyang Zheng,Zeng Jianing,Akinsanya Billy,Valentine Jack L.,Moehlenkamp Jeffrey D.,Deng Yuzhong,Aubry Anne-Françoise,Arnold Mark E.

Publisher

Elsevier BV

Subject

Cell Biology,Clinical Biochemistry,Biochemistry,General Medicine,Analytical Chemistry

Reference13 articles.

1. Direct acting antivirals for the treatment of chronic hepatitis C: one pill a day for tomorrow

2. Inhibitors of the Hepatitis C Virus RNA-Dependent RNA Polymerase NS5B

3. Discovery and Preclinical Characterization of the Cyclopropylindolobenzazepine BMS-791325, A Potent Allosteric Inhibitor of the Hepatitis C Virus NS5B Polymerase

4. Preclinical Characterization of BMS-791325, an Allosteric Inhibitor of Hepatitis C Virus NS5B Polymerase

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Three Smart and Original Spectrophotometric Data Processing Ratio Techniques for Resolving the Partial Overlapped Spectra of the Binary Antiviral Mixture Daclatasvir/Sofosbuvir: Application to Combined Dosage Form Darvoni® Tablets;Journal of AOAC INTERNATIONAL;2021-12-10

2. Fabrication of an electrochemical sensor based on manganese oxide nanoparticles supported on reduced graphene oxide for determination of subnanomolar level of anti-hepatitis C daclatasvir in the formulation and biological models;Microchemical Journal;2020-09

3. Tandem mass spectrometry of small-molecule antiviral drugs: 2. hepatitis-related antivirals;International Journal of Mass Spectrometry;2020-09

4. Effect of CYP3A5*3 genetic variant on the metabolism of direct-acting antivirals in vitro: a different effect on asunaprevir versus daclatasvir and beclabuvir;Journal of Human Genetics;2019-10-23

5. Novel spectrophotometric and factor-based multivariate calibration-prediction techniques for determination of two inhibitors of hepatitis C-virus and hepatocellular carcinoma in pure, human urine, and human plasma;Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy;2019-04